Michael Ramos
@_MichaelRamos_
Followers
281
Following
2K
Media
11
Statuses
212
MS5 @CleClinicLCM currently | @Princeton and @CWRU previously | aspiring orthopedic surgeon 🦴
Cleveland, OH
Joined July 2021
Cleveland Clinic Adult Reconstruction Research - Holiday Party 🎄🦴✨ Amazing CCARR Holiday Party! Grateful for this team, your stories, your growth, and the impact you make every day. Honored to walk this journey with you. 🤍🙌 #CCARR #TeamS
#ClevelandClinic #Orthopaedics 🎉
0
1
3
A great year of research no doubt! Thank you @nspiuzzi @DrMattDeren
👏🎓 Congratulations to Michael Ramos, MD (@ClevelandClinic @_MichaelRamos_ ) on successfully defending his thesis: “Understanding the Clinical Outcomes of Modular Fluted Tapered Stems in Aseptic Revision Total Hip Arthroplasty.” A year of resilience, growth, and impact in
0
1
14
Great to have attended the 2nd Annual @CciMeetings ROCKS! It’s amazing to learn of the waves robotics are making in joint arthroplasty.
0
2
7
One of the cooler watch interviews I've seen, largely because it's not just some rich guy who buys expensive watches. Adam Romanov is a mountain climber and former diplomat who has great taste in watches and actually does things in his timepieces. via YouTube the1916company
27
48
1K
A “1.5-stage” spacer construct using stemmed-revision components was associated with promising short-term results. Durable spacer constructs may be a viable option for select patients. https://t.co/LAE1qLNTxR
6
6
65
In patients 75yo and older undergoing aseptic revision THA with modular fluted tapered stems, the cumulative incidence of reoperation was 6.1% at 2yr. The MFT stem remains an acceptable option in older patients undergoing aseptic revision THA. https://t.co/i925fJJENI
2
3
31
A truly global 🌍, multidisciplinary effort this week at #ICM2025 🇹🇷—1,200+ experts uniting to confront one of orthopaedics’ toughest challenges: MUSCULOSKELETAL INFECTIONS - and mainly periprosthetic joint infection! Incredible energy, collaboration & hope as we redefine the
0
3
13
Musculoskeletal interventions are often perceived as low-risk in the context of other medical treatments. However, our meta-analysis challenges this assumption and demonstrates the unfortunate fact that PJI may lead to mortality rates equivalent to common cancers. #orthotwitter
Great work from @_MichaelRamos_ and the team on this important meta-analysis in @JArthroplasty ! 👏 📅 Mortality after PJI following THA: • 1 month: 2.2% • 1 year: 10.6% ⚠️ Highest with 2-stage revision 📊 Comparable to 5-year mortality for melanoma, breast & prostate cancer
1
4
9
🚨PJI after THA is a serious complication and demands multidisciplinary care teams and increased research funding. 🚨 Many thanks to the team for seeing this project through! https://t.co/arGRcDTnSG
1
4
19
Some final Masters thoughts. 1. Five is so many. Adam Scott, JT and Scottie combined. It's so, so many. Only 14 players since WW2 have won five or more. Tying Brooks and Seve with the best golf of your life, and now, improbably, Palmer is back in play.
118
146
8K
Our 2025 orthopaedic match panel showcases 6 exceptional applicants who recently matched into top institutions nationwide. We are proud to call them our friends and peer mentors, and hope that our listeners can learn as much from their journeys as we do. #orthoX #orthotwitter
1
5
19
Strong teams aren’t built by chance — they’re built by time, trust, and shared experiences To work like a team, we need to be a team — that means time together Huge thanks to the CCARR crew — we missed those who couldn’t make it! #CCARR Let’s keep building! Cleveland Clinic
2
3
15
What an incredible week at AAOS in San Diego! Truly honored to have won the Kappa Delta Young Investigator award with @nspiuzzi such a meaningful recognition of our work! Loved presenting our research alongside so many brilliant papers. So many other fun moments with friends
1
2
30
🦠 Periprosthetic Joint Infection (PJI) has a 4-year mortality of 11.6%, higher than some cancers! 📊🔬 🔹 Healthy 67-year-old: 5% mortality (PJI = 2.3x risk) 🔹 Melanoma: 7% mortality (PJI = 1.7x risk) 🔹 Prostate Cancer: 2% mortality (PJI = 5.8x risk) 🔹 Breast Cancer: 10%
1
10
39